ESTAZOLAM

ESTAZOLAM was reported 1983 times

ESTAZOLAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXTRINSIC VASCULAR COMPRESSION 2 0.1818
1 TESTICULAR OPERATION 4 0.0714
2 ANTIDEPRESSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0690
3 DISEASE RISK FACTOR 12 0.0299
4 GASTROINTESTINAL ENDOSCOPIC THERAPY 2 0.0290
5 HERNIA CONGENITAL 2 0.0290
6 KLEPTOMANIA 2 0.0274
7 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 2 0.0253
8 AUTOIMMUNE MYOCARDITIS 5 0.0228
9 AEROMONA INFECTION 1 0.0217
10 DELUSION OF REFERENCE 3 0.0216
11 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 2 0.0213
12 DISUSE SYNDROME 2 0.0172
13 TONGUE BLACK HAIRY 2 0.0168
14 DRUG-DISEASE INTERACTION 12 0.0163
15 GLOMERULONEPHRITIS CHRONIC 3 0.0160
16 NIPPLE SWELLING 4 0.0159
17 BLADDER DISTENSION 2 0.0159
18 POVERTY OF SPEECH 6 0.0153
19 SHIFT TO THE LEFT 3 0.0146
20 ATRIOVENTRICULAR DISSOCIATION 3 0.0140
21 RABBIT SYNDROME 2 0.0120
22 PROCEDURAL HYPOTENSION 10 0.0118
23 ANTIDEPRESSANT DRUG LEVEL INCREASED 4 0.0113
24 BLOOD CHOLINESTERASE DECREASED 3 0.0109
25 LIMB IMMOBILISATION 2 0.0108
26 PARANEOPLASTIC SYNDROME 7 0.0104
27 MYOTONIA 2 0.0090
28 CD4 LYMPHOCYTES INCREASED 2 0.0086
29 SUBSTANCE DEPENDENCE 5 0.0074
30 BACTERIAL TRANSLOCATION 2 0.0063
31 PERIVASCULAR DERMATITIS 2 0.0060
32 SUBSTANCE USE DISORDER 19 0.0060
33 CUBITAL TUNNEL SYNDROME 2 0.0059
34 HYPERAMMONAEMIC ENCEPHALOPATHY 10 0.0057
35 LEFT ATRIAL ENLARGEMENT 3 0.0056
36 ADULTERATED PRODUCT 1 0.0050
37 MASKED FACIES 2 0.0049
38 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
39 PERSECUTORY DELUSION 12 0.0048
40 HYPERFERRITINAEMIA 2 0.0046
41 JOB DISSATISFACTION 3 0.0046
42 PNEUMOCOCCAL SEPSIS 3 0.0046
43 VASCULAR DEMENTIA 4 0.0046
44 UPPER AIRWAY OBSTRUCTION 4 0.0045
45 HYPERAMMONAEMIA 22 0.0044
46 EXTENSOR PLANTAR RESPONSE 4 0.0043
47 HAEMANGIOMA CONGENITAL 2 0.0042
48 CARDIAC DEATH 5 0.0041
49 OSMOTIC DEMYELINATION SYNDROME 3 0.0041
50 SKIN OEDEMA 4 0.0040
51 WATER INTOXICATION 2 0.0040
52 NECROTISING COLITIS 5 0.0039
53 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
54 METASTASES TO KIDNEY 2 0.0036
55 BLOOD PH INCREASED 2 0.0036
56 MYOCARDIAL INJURY 4 0.0036
57 VENTRICULAR ARRHYTHMIA 13 0.0036
58 URETHRAL PAIN 2 0.0034
59 HYPERTHERMIA MALIGNANT 5 0.0034
60 SINUS NODE DYSFUNCTION 6 0.0033
61 DISORGANISED SPEECH 6 0.0033
62 METASTASES TO ADRENALS 3 0.0033
63 HYPOPROTEINAEMIA 6 0.0032
64 TESTICULAR SWELLING 4 0.0032
65 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
66 EXTREMITY CONTRACTURE 2 0.0031
67 MITRAL VALVE CALCIFICATION 2 0.0031
68 STUPOR 10 0.0031
69 MULTIPLE DRUG OVERDOSE INTENTIONAL 10 0.0031
70 BLOOD CHLORIDE DECREASED 8 0.0031
71 BONE MARROW DEPRESSION 3 0.0031
72 HYPERMAGNESAEMIA 2 0.0031
73 COMPULSIONS 2 0.0030
74 HEAT ILLNESS 2 0.0030
75 LONG QT SYNDROME 7 0.0029
76 MIOSIS 23 0.0029
77 DELAYED GRAFT FUNCTION 2 0.0028
78 PUBIS FRACTURE 2 0.0028
79 SYMPTOM MASKED 2 0.0027
80 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 28 0.0027
81 PUPILLARY REFLEX IMPAIRED 5 0.0027
82 COMA HEPATIC 2 0.0027
83 SEROTONIN SYNDROME 51 0.0027
84 REFLUX OESOPHAGITIS 2 0.0026
85 NEGATIVISM 2 0.0026
86 HEAT STROKE 4 0.0026
87 HYPOCHLORAEMIA 3 0.0026
88 DIARRHOEA INFECTIOUS 2 0.0025
89 HYPERURICAEMIA 10 0.0024
90 HYDROTHORAX 2 0.0024
91 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
92 INTESTINAL DILATATION 3 0.0022
93 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
94 HYPERTHERMIA 17 0.0022
95 CHRONIC GASTRITIS 5 0.0022
96 PLEUROTHOTONUS 2 0.0022
97 MONOPARESIS 4 0.0022
98 MUCOSAL EROSION 2 0.0022
99 EFFUSION 3 0.0022
100 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
101 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 11 0.0021
102 VENOUS INJURY 2 0.0021
103 RHEUMATOID LUNG 2 0.0021
104 EPIDERMAL NECROSIS 2 0.0021
105 SUDDEN CARDIAC DEATH 7 0.0021
106 NODAL RHYTHM 3 0.0020
107 HYPERREFLEXIA 7 0.0020
108 ALTERED STATE OF CONSCIOUSNESS 43 0.0020
109 HYPOALBUMINAEMIA 15 0.0019
110 ABDOMINAL INJURY 1 0.0019
111 ALBUMINURIA 1 0.0019
112 BIPOLAR I DISORDER 4 0.0018
113 BLOOD FIBRINOGEN DECREASED 2 0.0018
114 SOPOR 23 0.0017
115 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
116 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
117 SCHIZOAFFECTIVE DISORDER 3 0.0017
118 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
119 SLOW SPEECH 4 0.0016
120 IMMUNE-MEDIATED LUNG DISEASE 3 0.0016
121 GLUCOSE URINE PRESENT 2 0.0016
122 LEFT ATRIAL DILATATION 2 0.0016
123 DISSEMINATED INTRAVASCULAR COAGULATION 22 0.0016
124 ALCOHOL INTERACTION 3 0.0015
125 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
126 FEELING GUILTY 2 0.0015
127 SUDDEN DEATH 16 0.0015
128 HYPERLACTACIDAEMIA 4 0.0015
129 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
130 SUBILEUS 3 0.0014
131 ANAL HAEMORRHAGE 4 0.0014
132 RENAL TUBULAR DISORDER 4 0.0014
133 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
134 BUNDLE BRANCH BLOCK LEFT 6 0.0014
135 DELIRIUM 49 0.0014
136 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
137 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
138 POST HERPETIC NEURALGIA 2 0.0014
139 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
140 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
141 HYPOPHOSPHATAEMIA 10 0.0014
142 IMPULSIVE BEHAVIOUR 5 0.0013
143 MIXED LIVER INJURY 4 0.0013
144 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
145 ECCHYMOSIS 9 0.0013
146 CHEST X-RAY ABNORMAL 4 0.0013
147 VIOLENCE-RELATED SYMPTOM 2 0.0013
148 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
149 SINUS ARREST 2 0.0013
150 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
151 TESTICULAR PAIN 4 0.0013
152 SKIN EROSION 4 0.0012
153 ORAL INTAKE REDUCED 3 0.0012
154 HYPERTONIA 7 0.0012
155 BREAST ENLARGEMENT 4 0.0012
156 SEBORRHOEIC DERMATITIS 2 0.0012
157 ILLUSION 2 0.0012
158 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
159 DRUG USE DISORDER 10 0.0012
160 SUICIDE ATTEMPT 72 0.0012
161 BLOOD PH DECREASED 2 0.0012
162 PHYSICAL DECONDITIONING 3 0.0012
163 AORTIC ARTERIOSCLEROSIS 3 0.0012
164 ADENOMA BENIGN 1 0.0012
165 SPONDYLOLISTHESIS 2 0.0012
166 SPINAL CORD INJURY 2 0.0011
167 PSEUDOMONAL SEPSIS 2 0.0011
168 LOGORRHOEA 4 0.0011
169 VOCAL CORD PARALYSIS 2 0.0011
170 MOUTH HAEMORRHAGE 8 0.0011
171 IMMUNE-MEDIATED MYOSITIS 3 0.0011
172 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
173 ABULIA 1 0.0011
174 ADENOCARCINOMA GASTRIC 1 0.0011
175 ANGINA UNSTABLE 7 0.0011
176 PROTEIN TOTAL DECREASED 4 0.0011
177 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
178 HYPOVOLAEMIC SHOCK 5 0.0010
179 THYROID MASS 4 0.0010
180 HYPERTONIC BLADDER 3 0.0010
181 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
182 TACHYPNOEA 14 0.0010
183 SPINAL CORD COMPRESSION 4 0.0010
184 PYELONEPHRITIS ACUTE 2 0.0010
185 OCCULT BLOOD POSITIVE 2 0.0010
186 PNEUMONIA FUNGAL 4 0.0010
187 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
188 HYPOPHYSITIS 2 0.0010
189 SINUS TACHYCARDIA 14 0.0010
190 PNEUMONIA BACTERIAL 9 0.0010
191 DIVERTICULAR PERFORATION 2 0.0010
192 PNEUMONIA ASPIRATION 24 0.0010
193 POISONING 12 0.0010
194 HALLUCINATIONS, MIXED 4 0.0010
195 POISONING DELIBERATE 9 0.0009
196 ELECTROLYTE IMBALANCE 11 0.0009
197 ORTHOPNOEA 3 0.0009
198 CARDIAC FAILURE CHRONIC 4 0.0009
199 HYPERPHOSPHATAEMIA 2 0.0009
200 BEHAVIOUR DISORDER 5 0.0009
201 HEPATITIS ACUTE 6 0.0009
202 LYMPHOCYTE COUNT INCREASED 3 0.0009
203 RHABDOMYOLYSIS 38 0.0009
204 SCHIZOPHRENIA 11 0.0009
205 CYTOLYTIC HEPATITIS 3 0.0009
206 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
207 HEPATIC CYST 3 0.0009
208 DRUG INTERACTION 140 0.0009
209 CHOLECYSTITIS ACUTE 5 0.0009
210 COMA 42 0.0009
211 INTENTIONAL OVERDOSE 56 0.0009
212 DIFFICULTY IN WALKING 3 0.0009
213 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
214 BLOOD URIC ACID INCREASED 5 0.0009
215 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
216 SUBSTANCE ABUSE 7 0.0009
217 DECUBITUS ULCER 7 0.0009
218 HANGOVER 3 0.0009
219 LYMPHOCYTE COUNT DECREASED 15 0.0008
220 ACUTE LUNG INJURY 1 0.0008
221 HEPATIC FUNCTION ABNORMAL 31 0.0008
222 PANNICULITIS 2 0.0008
223 SELF ESTEEM DECREASED 2 0.0008
224 CIRCULATORY COLLAPSE 14 0.0008
225 HALLUCINATION, AUDITORY 13 0.0008
226 TRANSPLANT FAILURE 2 0.0008
227 PARADOXICAL DRUG REACTION 3 0.0008
228 MYOPATHY 7 0.0008
229 ARRHYTHMIA 38 0.0008
230 HYPERPARATHYROIDISM SECONDARY 2 0.0008
231 OSTEITIS 2 0.0008
232 DYSPHORIA 4 0.0008
233 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
234 PARKINSON'S DISEASE 2 0.0008
235 ANGLE CLOSURE GLAUCOMA 2 0.0008
236 GALACTORRHOEA 5 0.0008
237 ADJUSTMENT DISORDER 1 0.0008
238 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
239 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
240 PERSONALITY DISORDER 2 0.0008
241 LUNG OPACITY 2 0.0008
242 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
243 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
244 CHOLECYSTITIS CHRONIC 5 0.0007
245 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
246 BLOOD SODIUM INCREASED 2 0.0007
247 NEUTROPHIL COUNT DECREASED 30 0.0007
248 BRADYCARDIA 39 0.0007
249 ASPHYXIA 6 0.0007
250 DRUG LEVEL INCREASED 12 0.0007
251 DROOLING 5 0.0007
252 GASTROINTESTINAL PERFORATION 3 0.0007
253 HYPOKALAEMIA 33 0.0007
254 HAEMODIALYSIS 6 0.0007
255 HYPERPYREXIA 3 0.0007
256 AORTIC VALVE INCOMPETENCE 3 0.0007
257 MYDRIASIS 9 0.0007
258 ENTEROCOLITIS 4 0.0007
259 COMA SCALE ABNORMAL 2 0.0007
260 GASTROINTESTINAL NECROSIS 2 0.0007
261 MUSCLE RIGIDITY 8 0.0007
262 PROTHROMBIN TIME PROLONGED 4 0.0007
263 ATYPICAL PNEUMONIA 2 0.0007
264 MYOSITIS 6 0.0007
265 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
266 CEREBROVASCULAR DISORDER 2 0.0007
267 LEUKOCYTOSIS 12 0.0007
268 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
269 BLOOD UREA INCREASED 11 0.0007
270 HYPONATRAEMIA 37 0.0007
271 SELF INJURIOUS BEHAVIOUR 2 0.0007
272 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
273 LUMBAR VERTEBRAL FRACTURE 3 0.0007
274 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
275 MASTICATION DISORDER 2 0.0007
276 ILEUS 8 0.0006
277 BLOOD SODIUM DECREASED 12 0.0006
278 BLOOD ALBUMIN DECREASED 5 0.0006
279 RENAL CYST 5 0.0006
280 ACUTE LEUKAEMIA 1 0.0006
281 LIVER ABSCESS 2 0.0006
282 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
283 MYOCARDIAL ISCHAEMIA 7 0.0006
284 BACTERIAL SEPSIS 2 0.0006
285 HEPATIC NEOPLASM 2 0.0006
286 BRADYPHRENIA 4 0.0006
287 ABNORMAL FAECES 5 0.0006
288 HYPERAESTHESIA 5 0.0006
289 MULTIPLE DRUG OVERDOSE 3 0.0006
290 PULMONARY MASS 9 0.0006
291 EXTRAPYRAMIDAL DISORDER 15 0.0006
292 PROTEIN URINE PRESENT 3 0.0006
293 THERAPEUTIC AGENT TOXICITY 2 0.0006
294 SALIVARY HYPERSECRETION 6 0.0006
295 NEPHRITIS 2 0.0006
296 POTENTIATING DRUG INTERACTION 2 0.0006
297 AGRANULOCYTOSIS 11 0.0006
298 BACTERAEMIA 7 0.0006
299 AKATHISIA 8 0.0006
300 HYPOCALCAEMIA 11 0.0006
301 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
302 BLOOD CREATININE ABNORMAL 2 0.0006
303 DEPRESSION SUICIDAL 2 0.0006
304 HYPOPNOEA 2 0.0006
305 CEREBRAL INFARCTION 14 0.0006
306 ACUTE RESPIRATORY FAILURE 11 0.0006
307 DEPRESSIVE SYMPTOM 2 0.0006
308 JAUNDICE CHOLESTATIC 2 0.0006
309 FIBRIN D DIMER INCREASED 2 0.0006
310 COMPRESSION FRACTURE 3 0.0006
311 APPARENT DEATH 2 0.0006
312 FAECES SOFT 4 0.0005
313 MAJOR DEPRESSION 4 0.0005
314 MANIA 9 0.0005
315 TOXICITY TO VARIOUS AGENTS 92 0.0005
316 HYPOMANIA 2 0.0005
317 HYPERKERATOSIS 3 0.0005
318 PSYCHIATRIC SYMPTOM 4 0.0005
319 AMYLASE INCREASED 2 0.0005
320 GASTRIC ULCER HAEMORRHAGE 3 0.0005
321 BONE MARROW FAILURE 11 0.0005
322 RETINOPATHY 2 0.0005
323 HYDRONEPHROSIS 4 0.0005
324 ADENOCARCINOMA OF COLON 1 0.0005
325 SNORING 2 0.0005
326 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
327 COMMUNICATION DISORDER 2 0.0005
328 GASTRIC HAEMORRHAGE 6 0.0005
329 OESOPHAGEAL ULCER 2 0.0005
330 SINUS BRADYCARDIA 5 0.0005
331 RALES 3 0.0005
332 LUNG INFECTION 8 0.0005
333 PARKINSONISM 5 0.0005
334 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
335 HYPERTRIGLYCERIDAEMIA 3 0.0005
336 NAIL DISCOLOURATION 2 0.0005
337 DRUG ERUPTION 9 0.0005
338 THIRST 9 0.0005
339 BLADDER DISORDER 5 0.0005
340 GINGIVAL PAIN 4 0.0005
341 HYPERLIPIDAEMIA 6 0.0005
342 COORDINATION ABNORMAL 7 0.0005
343 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
344 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
345 PERIPHERAL ISCHAEMIA 2 0.0005
346 GOITRE 2 0.0005
347 NEUTROPHIL COUNT INCREASED 5 0.0005
348 LARYNGEAL OEDEMA 3 0.0005
349 PIGMENTATION DISORDER 3 0.0005
350 SPINAL STENOSIS 2 0.0005
351 SCOLIOSIS 3 0.0005
352 VENTRICULAR EXTRASYSTOLES 5 0.0005
353 PRE-EXISTING CONDITION IMPROVED 3 0.0005
354 DISORIENTATION 19 0.0005
355 SELF-INJURIOUS IDEATION 2 0.0005
356 BRAIN OEDEMA 6 0.0005
357 TACHYCARDIA 42 0.0005
358 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
359 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
360 LUNG NEOPLASM 2 0.0005
361 SHOULDER OPERATION 2 0.0005
362 DYSURIA 17 0.0005
363 CARDIAC FAILURE 37 0.0005
364 DIVERTICULUM INTESTINAL 2 0.0005
365 PULMONARY CONGESTION 6 0.0005
366 CORONAVIRUS INFECTION 3 0.0005
367 ACCIDENT AT WORK 1 0.0005
368 RESPIRATORY FAILURE 33 0.0005
369 DELUSION 7 0.0005
370 RESPIRATORY RATE INCREASED 4 0.0005
371 RHINITIS ALLERGIC 2 0.0004
372 LIVER INJURY 11 0.0004
373 OBESITY 7 0.0004
374 INTERSTITIAL LUNG DISEASE 21 0.0004
375 UROSEPSIS 4 0.0004
376 LARGE INTESTINE POLYP 3 0.0004
377 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
378 HYPOMAGNESAEMIA 6 0.0004
379 RENAL FUNCTION TEST ABNORMAL 2 0.0004
380 EXTRASYSTOLES 3 0.0004
381 HEPATIC STEATOSIS 8 0.0004
382 ERYTHEMA MULTIFORME 4 0.0004
383 LIVER DISORDER 19 0.0004
384 SEDATION 11 0.0004
385 PARALYSIS 6 0.0004
386 IMPAIRED QUALITY OF LIFE 6 0.0004
387 MYELOSUPPRESSION 15 0.0004
388 DIABETIC KETOACIDOSIS 10 0.0004
389 AFFECT LABILITY 4 0.0004
390 ENTEROCOCCAL INFECTION 2 0.0004
391 SEPTIC SHOCK 18 0.0004
392 HYPOKINESIA 6 0.0004
393 SOMNOLENCE 83 0.0004
394 ADRENAL INSUFFICIENCY 5 0.0004
395 THROMBOCYTOPENIA 46 0.0004
396 RENAL CELL CARCINOMA 2 0.0004
397 RESPIRATORY DEPRESSION 5 0.0004
398 RENAL TUBULAR NECROSIS 4 0.0004
399 BODY TEMPERATURE DECREASED 4 0.0004
400 STAPHYLOCOCCAL SEPSIS 2 0.0004
401 ORGANISING PNEUMONIA 2 0.0004
402 PULMONARY OEDEMA 18 0.0004
403 SPEECH DISORDER 21 0.0004
404 DERMATITIS EXFOLIATIVE 2 0.0004
405 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
406 INTENTIONAL SELF-INJURY 8 0.0004
407 HYPOTHERMIA 4 0.0004
408 DYSLIPIDAEMIA 2 0.0004
409 MUSCLE TWITCHING 9 0.0004
410 URINARY RETENTION 13 0.0004
411 CEREBRAL ISCHAEMIA 2 0.0004
412 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
413 VARICOSE VEIN 2 0.0004
414 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
415 EJECTION FRACTION DECREASED 6 0.0004
416 SKIN NECROSIS 2 0.0004
417 COMPLETED SUICIDE 32 0.0004
418 PULMONARY HAEMORRHAGE 3 0.0004
419 DRUG-INDUCED LIVER INJURY 12 0.0004
420 AFFECTIVE DISORDER 3 0.0004
421 LEUKOPENIA 19 0.0004
422 MOUTH ULCERATION 8 0.0004
423 TRICUSPID VALVE INCOMPETENCE 3 0.0004
424 ANORECTAL DISCOMFORT 2 0.0004
425 PLATELET COUNT DECREASED 40 0.0004
426 BACTERIAL INFECTION 7 0.0004
427 MIDDLE INSOMNIA 7 0.0004
428 ABDOMINAL MASS 1 0.0004
429 DRUG ABUSE 31 0.0004
430 DRY MOUTH 30 0.0004
431 BIPOLAR DISORDER 4 0.0004
432 ESCHERICHIA INFECTION 3 0.0004
433 PERIPHERAL COLDNESS 5 0.0004
434 MELAENA 8 0.0004
435 VENTRICULAR TACHYCARDIA 6 0.0004
436 INTESTINAL ISCHAEMIA 2 0.0004
437 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
438 ACUTE CORONARY SYNDROME 3 0.0004
439 EOSINOPHIL COUNT INCREASED 3 0.0004
440 STEVENS-JOHNSON SYNDROME 8 0.0004
441 LOSS OF CONSCIOUSNESS 46 0.0004
442 C-REACTIVE PROTEIN INCREASED 13 0.0004
443 SENSATION OF FOREIGN BODY 3 0.0004
444 STATUS EPILEPTICUS 4 0.0004
445 INADEQUATE ANALGESIA 3 0.0004
446 UNRESPONSIVE TO STIMULI 9 0.0003
447 ANURIA 3 0.0003
448 NEOPLASM 4 0.0003
449 HERPES VIRUS INFECTION 2 0.0003
450 HYPERTHYROIDISM 5 0.0003
451 HYPERVENTILATION 2 0.0003
452 DYSKINESIA 14 0.0003
453 STRESS CARDIOMYOPATHY 2 0.0003
454 HYPERKALAEMIA 12 0.0003
455 HYPOVOLAEMIA 2 0.0003
456 SPINAL OSTEOARTHRITIS 3 0.0003
457 SEXUAL DYSFUNCTION 4 0.0003
458 AGITATION 25 0.0003
459 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
460 DECREASED INTEREST 2 0.0003
461 ENERGY INCREASED 2 0.0003
462 OXYGEN SATURATION DECREASED 19 0.0003
463 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
464 MYOCLONUS 4 0.0003
465 GASTROINTESTINAL INFECTION 3 0.0003
466 ANAL INCONTINENCE 3 0.0003
467 BLOOD BILIRUBIN INCREASED 9 0.0003
468 THYROID CANCER 4 0.0003
469 OROPHARYNGEAL DISCOMFORT 3 0.0003
470 HEPATITIS B 2 0.0003
471 GANGRENE 2 0.0003
472 HALLUCINATION, VISUAL 7 0.0003
473 BLOOD PRESSURE DECREASED 22 0.0003
474 DERMATITIS ACNEIFORM 2 0.0003
475 POOR QUALITY SLEEP 7 0.0003
476 SMALL INTESTINAL OBSTRUCTION 4 0.0003
477 HYPERCALCAEMIA 4 0.0003
478 GENERALISED OEDEMA 4 0.0003
479 APPENDICITIS 3 0.0003
480 PHOTOPSIA 2 0.0003
481 GASTRIC ULCER 6 0.0003
482 PNEUMOTHORAX 5 0.0003
483 DISTURBANCE IN ATTENTION 17 0.0003
484 ANGINA PECTORIS 9 0.0003
485 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
486 HERPES ZOSTER 18 0.0003
487 METABOLIC ACIDOSIS 10 0.0003
488 ENTERITIS 2 0.0003
489 HYPOXIA 11 0.0003
490 HYPERCHOLESTEROLAEMIA 3 0.0003
491 ANOREXIA 4 0.0003
492 ANAPHYLACTIC SHOCK 8 0.0003
493 WITHDRAWAL SYNDROME 13 0.0003
494 CARDIAC FLUTTER 2 0.0003
495 HYPOGLYCAEMIA 15 0.0003
496 INCOHERENT 2 0.0003
497 RENAL FAILURE ACUTE 13 0.0003
498 PSYCHOTIC DISORDER 9 0.0003
499 SOMNAMBULISM 2 0.0003
500 BEDRIDDEN 4 0.0003
501 INSOMNIA 81 0.0003
502 WALKING AID USER 2 0.0003
503 FEBRILE NEUTROPENIA 20 0.0003
504 CARDIAC FAILURE ACUTE 2 0.0003
505 CONVULSION 17 0.0003
506 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
507 MOTOR DYSFUNCTION 3 0.0003
508 DRUG TOXICITY 4 0.0003
509 INFARCTION 2 0.0003
510 MUSCULOSKELETAL DISCOMFORT 5 0.0003
511 RESPIRATORY ARREST 8 0.0003
512 ENCEPHALITIS 2 0.0003
513 HAIR GROWTH ABNORMAL 2 0.0003
514 ANAEMIA 55 0.0003
515 HYPERTRANSAMINASAEMIA 2 0.0003
516 HYPERHIDROSIS 37 0.0003
517 CARDIO-RESPIRATORY ARREST 12 0.0003
518 DEPRESSED MOOD 15 0.0003
519 EATING DISORDER 6 0.0003
520 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
521 BODY HEIGHT DECREASED 3 0.0003
522 AGGRESSION 14 0.0003
523 SUBDURAL HAEMATOMA 4 0.0003
524 CARDIOGENIC SHOCK 4 0.0003
525 GRAFT VERSUS HOST DISEASE 2 0.0003
526 SEPSIS 31 0.0003
527 MYELODYSPLASTIC SYNDROME 4 0.0003
528 MENTAL DISORDER 12 0.0003
529 RASH PUSTULAR 2 0.0003
530 CHOLELITHIASIS 9 0.0003
531 UTERINE LEIOMYOMA 2 0.0003
532 TOOTH FRACTURE 3 0.0003
533 VENTRICULAR FIBRILLATION 3 0.0003
534 URINARY INCONTINENCE 8 0.0003
535 PNEUMONIA 87 0.0003
536 INTESTINAL PERFORATION 3 0.0003
537 PANCREATITIS ACUTE 6 0.0003
538 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
539 HEART RATE IRREGULAR 6 0.0003
540 REBOUND EFFECT 3 0.0003
541 TROPONIN INCREASED 2 0.0003
542 HAEMODYNAMIC INSTABILITY 2 0.0003
543 MYOCARDITIS 3 0.0003
544 EPILEPSY 8 0.0003
545 LIPASE INCREASED 2 0.0003
546 RENAL FAILURE CHRONIC 2 0.0003
547 OVERDOSE 56 0.0003
548 PERICARDIAL EFFUSION 6 0.0003
549 TREMOR 43 0.0003
550 ATRIOVENTRICULAR BLOCK 2 0.0003
551 EYELID OEDEMA 3 0.0003
552 DYSTONIA 5 0.0003
553 PALLOR 7 0.0003
554 COGNITIVE DISORDER 12 0.0003
555 APNOEA 2 0.0003
556 ACUTE MYELOID LEUKAEMIA 4 0.0003
557 CHOKING 5 0.0003
558 SPLENOMEGALY 3 0.0003
559 TORSADE DE POINTES 2 0.0003
560 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
561 COVID-19 PNEUMONIA 3 0.0003
562 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
563 ULCER 4 0.0003
564 PRODUCTIVE COUGH 12 0.0003
565 HAEMOPTYSIS 7 0.0003
566 ATRIAL FLUTTER 2 0.0003
567 RHINITIS 2 0.0002
568 LACTIC ACIDOSIS 8 0.0002
569 HYPERGLYCAEMIA 9 0.0002
570 FEEDING DISORDER 5 0.0002
571 NO THERAPEUTIC RESPONSE 3 0.0002
572 POST PROCEDURAL INFECTION 2 0.0002
573 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
574 ABASIA 6 0.0002
575 SPINAL COMPRESSION FRACTURE 2 0.0002
576 PHARYNGITIS 3 0.0002
577 PERITONITIS 5 0.0002
578 MUSCLE INJURY 2 0.0002
579 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
580 PYREXIA 83 0.0002
581 INTENTIONAL PRODUCT MISUSE 21 0.0002
582 FACIAL PARALYSIS 2 0.0002
583 SCAR 4 0.0002
584 ALCOHOLISM 1 0.0002
585 PLATELET COUNT INCREASED 3 0.0002
586 URINE OUTPUT DECREASED 2 0.0002
587 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
588 IMMUNOSUPPRESSION 2 0.0002
589 LUNG INFILTRATION 2 0.0002
590 ABDOMINAL ABSCESS 1 0.0002
591 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
592 OEDEMA PERIPHERAL 27 0.0002
593 END STAGE RENAL DISEASE 4 0.0002
594 HIDRADENITIS 2 0.0002
595 EXOSTOSIS 2 0.0002
596 DEHYDRATION 29 0.0002
597 SHOCK 5 0.0002
598 NERVE COMPRESSION 2 0.0002
599 IRON DEFICIENCY ANAEMIA 2 0.0002
600 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
601 ORAL DISCOMFORT 3 0.0002
602 CONJUNCTIVITIS 4 0.0002
603 DEMENTIA 6 0.0002
604 THINKING ABNORMAL 4 0.0002
605 MASS 3 0.0002
606 RENAL DISORDER 10 0.0002
607 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
608 BLOOD CREATININE INCREASED 14 0.0002
609 HEPATIC ENCEPHALOPATHY 2 0.0002
610 RENAL IMPAIRMENT 18 0.0002
611 NEPHROPATHY 2 0.0002
612 PALPITATIONS 25 0.0002
613 FLANK PAIN 2 0.0002
614 STAPHYLOCOCCAL INFECTION 7 0.0002
615 SPUTUM DISCOLOURED 2 0.0002
616 PULMONARY EMBOLISM 20 0.0002
617 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
618 PROTEINURIA 4 0.0002
619 EYE INFLAMMATION 2 0.0002
620 ATELECTASIS 2 0.0002
621 HERNIA 4 0.0002
622 ERUCTATION 4 0.0002
623 DECREASED APPETITE 48 0.0002
624 GASTROENTERITIS 3 0.0002
625 DRUG DEPENDENCE 33 0.0002
626 CHEST DISCOMFORT 21 0.0002
627 HAEMATURIA 7 0.0002
628 ACUTE MYOCARDIAL INFARCTION 6 0.0002
629 LIGAMENT SPRAIN 2 0.0002
630 ABDOMINAL TENDERNESS 1 0.0002
631 HYPOTONIA 2 0.0002
632 IRRITABILITY 12 0.0002
633 EMPHYSEMA 2 0.0002
634 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
635 HAEMATEMESIS 5 0.0002
636 PLEURAL EFFUSION 12 0.0002
637 CARDIOVASCULAR DISORDER 5 0.0002
638 PANCYTOPENIA 11 0.0002
639 TOOTH ABSCESS 2 0.0002
640 BODY TEMPERATURE INCREASED 4 0.0002
641 ACUTE KIDNEY INJURY 30 0.0002
642 EUPHORIC MOOD 2 0.0002
643 INITIAL INSOMNIA 2 0.0002
644 DEVICE RELATED INFECTION 3 0.0002
645 EAR DISCOMFORT 2 0.0002
646 OSTEOPOROSIS 8 0.0002
647 TEMPERATURE INTOLERANCE 2 0.0002
648 CARDIAC ARREST 16 0.0002
649 MUSCULAR WEAKNESS 22 0.0002
650 URINARY TRACT INFECTION 33 0.0002
651 DEPRESSION 44 0.0002
652 CONSTIPATION 42 0.0002
653 THERAPY PARTIAL RESPONDER 3 0.0002
654 PANIC ATTACK 7 0.0002
655 TENDERNESS 2 0.0002
656 ASTHENIA 72 0.0002
657 INTENTIONAL DRUG MISUSE 4 0.0002
658 CYANOSIS 3 0.0002
659 OSTEOARTHRITIS 8 0.0002
660 CYSTITIS 6 0.0002
661 BONE PAIN 11 0.0002
662 MENSTRUATION IRREGULAR 5 0.0002
663 FEAR 5 0.0002
664 INTESTINAL OBSTRUCTION 7 0.0002
665 DECREASED ACTIVITY 2 0.0002
666 BLOOD POTASSIUM INCREASED 3 0.0002
667 PNEUMONITIS 5 0.0002
668 TREATMENT NONCOMPLIANCE 10 0.0002
669 WOUND INFECTION 2 0.0002
670 ASPIRATION 2 0.0002
671 HAEMATOCHEZIA 10 0.0002
672 DENTAL CARIES 2 0.0002
673 TRANSAMINASES INCREASED 4 0.0002
674 HEPATOTOXICITY 4 0.0002
675 MALNUTRITION 2 0.0002
676 ACUTE PULMONARY OEDEMA 1 0.0002
677 CANDIDA INFECTION 3 0.0002
678 TARDIVE DYSKINESIA 5 0.0002
679 MITRAL VALVE INCOMPETENCE 2 0.0002
680 HAEMOGLOBIN DECREASED 18 0.0002
681 HYPERSOMNIA 5 0.0002
682 NIGHTMARE 6 0.0002
683 DYSSTASIA 5 0.0002
684 CHRONIC KIDNEY DISEASE 13 0.0002
685 CHILLS 20 0.0002
686 ASCITES 5 0.0002
687 HYPERTENSION 36 0.0002
688 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
689 HYPOTENSION 34 0.0002
690 POLLAKIURIA 7 0.0002
691 ACCIDENT 2 0.0002
692 ROAD TRAFFIC ACCIDENT 7 0.0002
693 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
694 BLOOD POTASSIUM DECREASED 5 0.0002
695 OEDEMA 9 0.0002
696 TOOTHACHE 3 0.0002
697 CORONARY ARTERY DISEASE 5 0.0002
698 RESTLESS LEGS SYNDROME 3 0.0002
699 BURSITIS 2 0.0002
700 NOCTURIA 2 0.0002
701 ABDOMINAL DISTENSION 17 0.0002
702 BALANCE DISORDER 14 0.0002
703 NEUTROPENIA 22 0.0002
704 NERVOUS SYSTEM DISORDER 5 0.0002
705 DRUG WITHDRAWAL SYNDROME 14 0.0002
706 DYSARTHRIA 6 0.0002
707 COLITIS 6 0.0002
708 MUSCLE ATROPHY 2 0.0002
709 SLEEP APNOEA SYNDROME 3 0.0002
710 FALL 52 0.0002
711 POST PROCEDURAL COMPLICATION 3 0.0002
712 GLAUCOMA 3 0.0002
713 MOVEMENT DISORDER 5 0.0002
714 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
715 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
716 PRESCRIBED OVERDOSE 3 0.0002
717 HIATUS HERNIA 2 0.0002
718 ATRIAL FIBRILLATION 15 0.0002
719 BLOOD GLUCOSE INCREASED 29 0.0002
720 PLASMA CELL MYELOMA 6 0.0002
721 NEPHROLITHIASIS 7 0.0002
722 TINNITUS 7 0.0002
723 ANHEDONIA 4 0.0002
724 GASTRITIS 4 0.0002
725 GAIT DISTURBANCE 29 0.0002
726 ABNORMAL BEHAVIOUR 6 0.0002
727 ADVERSE REACTION 2 0.0002
728 BLOOD CHOLESTEROL INCREASED 7 0.0002
729 EYE HAEMORRHAGE 2 0.0001
730 GAIT INABILITY 5 0.0001
731 JOINT RANGE OF MOTION DECREASED 2 0.0001
732 QUALITY OF LIFE DECREASED 2 0.0001
733 JAUNDICE 4 0.0001
734 BRONCHITIS 11 0.0001
735 TYPE 2 DIABETES MELLITUS 5 0.0001
736 CONFUSIONAL STATE 24 0.0001
737 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
738 TASTE DISORDER 3 0.0001
739 PRODUCT TASTE ABNORMAL 2 0.0001
740 MOOD ALTERED 4 0.0001
741 RASH ERYTHEMATOUS 7 0.0001
742 ACUTE HEPATIC FAILURE 2 0.0001
743 CHEST PAIN 27 0.0001
744 DIVERTICULITIS 4 0.0001
745 PULMONARY HYPERTENSION 3 0.0001
746 DERMATITIS 3 0.0001
747 VOMITING 67 0.0001
748 BACK PAIN 33 0.0001
749 SUICIDAL IDEATION 13 0.0001
750 SLEEP DISORDER 10 0.0001
751 LYMPHOPENIA 2 0.0001
752 OROPHARYNGEAL PAIN 13 0.0001
753 LIVER FUNCTION TEST ABNORMAL 4 0.0001
754 ANXIETY 39 0.0001
755 ACCIDENTAL OVERDOSE 5 0.0001
756 RENAL INJURY 4 0.0001
757 COLON CANCER 2 0.0001
758 ORAL PAIN 3 0.0001
759 NERVOUSNESS 7 0.0001
760 HAEMORRHAGE 14 0.0001
761 HYPOAESTHESIA 20 0.0001
762 DYSPNOEA EXERTIONAL 5 0.0001
763 HALLUCINATION 10 0.0001
764 HEPATIC FAILURE 4 0.0001
765 DIZZINESS 66 0.0001
766 VERTIGO 8 0.0001
767 DISCOMFORT 8 0.0001
768 SKIN DISCOLOURATION 6 0.0001
769 DRUG ADMINISTRATION ERROR 4 0.0001
770 EMOTIONAL DISORDER 4 0.0001
771 FEELING ABNORMAL 31 0.0001
772 GYNAECOMASTIA 4 0.0001
773 BURNING SENSATION 9 0.0001
774 SWELLING 12 0.0001
775 RENAL FAILURE 17 0.0001
776 ARTHRITIS 10 0.0001
777 HEAD INJURY 4 0.0001
778 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
779 HYPOTHYROIDISM 4 0.0001
780 BLOOD PRESSURE FLUCTUATION 3 0.0001
781 ABDOMINAL PAIN 29 0.0001
782 SENSORY DISTURBANCE 2 0.0001
783 AMNESIA 8 0.0001
784 ENCEPHALOPATHY 3 0.0001
785 METASTASES TO BONE 2 0.0001
786 SEIZURE 14 0.0001
787 CYTOMEGALOVIRUS INFECTION 2 0.0001
788 VIRAL INFECTION 4 0.0001
789 COAGULOPATHY 2 0.0001
790 DYSPHONIA 7 0.0001
791 NASAL CONGESTION 7 0.0001
792 CONDITION AGGRAVATED 36 0.0001
793 DIABETES MELLITUS 9 0.0001
794 HEPATITIS 3 0.0001
795 THERAPY CESSATION 6 0.0001
796 ERYTHEMA 24 0.0001
797 MULTI-ORGAN FAILURE 2 0.0001
798 DIPLOPIA 3 0.0001
799 RESPIRATORY TRACT INFECTION 3 0.0001
800 FEELING HOT 7 0.0001
801 MALAISE 50 0.0001
802 LYMPHADENOPATHY 4 0.0001
803 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
804 RASH PRURITIC 6 0.0001
805 DRUG EFFECT INCOMPLETE 4 0.0001
806 CRYING 4 0.0001
807 FEELING COLD 3 0.0001
808 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
809 WOUND 3 0.0001
810 BLISTER 6 0.0001
811 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
812 FLATULENCE 6 0.0001
813 FRACTURE 2 0.0001
814 INFUSION RELATED REACTION 7 0.0001
815 FOOT FRACTURE 2 0.0001
816 BLOOD URINE PRESENT 2 0.0001
817 NEUROPATHY PERIPHERAL 10 0.0001
818 RED BLOOD CELL COUNT DECREASED 3 0.0001
819 INCREASED APPETITE 2 0.0001
820 PULMONARY FIBROSIS 2 0.0001
821 LOWER LIMB FRACTURE 2 0.0001
822 DRUG PRESCRIBING ERROR 2 0.0001
823 MUSCULOSKELETAL STIFFNESS 9 0.0001
824 HAEMORRHOIDS 2 0.0001
825 LUNG DISORDER 5 0.0001
826 KIDNEY INFECTION 2 0.0001
827 DYSPEPSIA 10 0.0001
828 HAEMATOCRIT DECREASED 2 0.0001
829 SYNCOPE 10 0.0001
830 CYTOKINE RELEASE SYNDROME 2 0.0001
831 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
832 DIARRHOEA 63 0.0001
833 ILLNESS 10 0.0001
834 LIMB DISCOMFORT 3 0.0001
835 FEMUR FRACTURE 3 0.0001
836 MOOD SWINGS 3 0.0001
837 IMPAIRED WORK ABILITY 2 0.0001
838 NIGHT SWEATS 3 0.0001
839 DRUG EFFECT DECREASED 5 0.0001
840 PRURITUS GENERALISED 2 0.0001
841 FAECES DISCOLOURED 2 0.0001
842 NASOPHARYNGITIS 17 0.0001
843 IMPAIRED HEALING 3 0.0001
844 VISUAL ACUITY REDUCED 3 0.0001
845 ARTHROPATHY 5 0.0001
846 TOOTH DISORDER 2 0.0001
847 ABDOMINAL DISCOMFORT 15 0.0001
848 SNEEZING 2 0.0001
849 EYE PAIN 5 0.0001
850 ABDOMINAL PAIN UPPER 18 0.0001
851 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
852 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
853 WHEEZING 5 0.0001
854 OCULAR HYPERAEMIA 4 0.0001
855 DISEASE RECURRENCE 4 0.0001
856 CATARACT 5 0.0001
857 MIGRAINE 8 0.0001
858 CEREBRAL HAEMORRHAGE 3 0.0001
859 MOBILITY DECREASED 6 0.0001
860 INFECTION 12 0.0001
861 DRUG INTOLERANCE 8 0.0001
862 MENTAL IMPAIRMENT 2 0.0001
863 STOMATITIS 5 0.0001
864 WEIGHT DECREASED 23 0.0001
865 FIBROMYALGIA 2 0.0001
866 NAUSEA 65 0.0001
867 HEADACHE 51 0.0001
868 DRY EYE 4 0.0001
869 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
870 ABDOMINAL PAIN LOWER 2 0.0001
871 PRODUCT COMPLAINT 2 0.0001
872 BLOOD PRESSURE INCREASED 12 0.0001
873 HYPOPHAGIA 2 0.0001
874 DRUG RESISTANCE 2 0.0001
875 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
876 RASH GENERALISED 2 0.0001
877 ARTHRALGIA 32 0.0001
878 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
879 DEAFNESS 2 0.0001
880 MYALGIA 13 0.0001
881 ECZEMA 4 0.0001
882 JOINT STIFFNESS 2 0.0001
883 COUGH 21 0.0001
884 CARDIAC FAILURE CONGESTIVE 6 0.0001
885 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
886 PAIN OF SKIN 2 0.0001
887 COVID-19 13 0.0001
888 FREQUENT BOWEL MOVEMENTS 2 0.0001
889 DYSPHAGIA 7 0.0001
890 LIMB INJURY 2 0.0001
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
892 RESPIRATORY DISTRESS 2 0.0001
893 ABNORMAL DREAMS 2 0.0001
894 TREATMENT FAILURE 6 0.0001
895 PROCEDURAL PAIN 2 0.0001
896 RASH 31 0.0001
897 ASTHMA 8 0.0001
898 DYSPNOEA 40 0.0001
899 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
900 PARAESTHESIA 11 0.0001
901 RECTAL HAEMORRHAGE 3 0.0001
902 LETHARGY 4 0.0001
903 ILL-DEFINED DISORDER 4 0.0001
904 VISION BLURRED 9 0.0001
905 MUSCLE SPASMS 12 0.0001
906 INJECTION SITE SWELLING 5 0.0001
907 HOSPITALISATION 10 0.0001
908 DRUG INEFFECTIVE 83 0.0001
909 ABSCESS 1 0.0001
910 PRURITUS 24 0.0001
911 CONTUSION 6 0.0001
912 OFF LABEL USE 54 0.0001
913 RHEUMATOID ARTHRITIS 7 0.0001
914 DEATH 53 0.0001
915 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
916 PAIN IN EXTREMITY 18 0.0001
917 HEART RATE INCREASED 6 0.0001
918 LIP SWELLING 2 0.0001
919 FUNGAL INFECTION 2 0.0001
920 SKIN DISORDER 2 0.0001
921 CELLULITIS 3 0.0001
922 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
923 SKIN EXFOLIATION 5 0.0001
924 FLUID RETENTION 3 0.0001
925 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
926 MEMORY IMPAIRMENT 8 0.0001
927 INFLAMMATION 3 0.0001
928 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
929 MYOCARDIAL INFARCTION 10 0.0001
930 MUSCULOSKELETAL PAIN 3 0.0001
931 PAIN 35 0.0001
932 ADVERSE DRUG REACTION 5 0.0001
933 FATIGUE 43 0.0001
934 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
935 RESTLESSNESS 2 0.0001
936 WEIGHT INCREASED 12 0.0001
937 PRODUCT SUBSTITUTION ISSUE 3 0.0001
938 PERIPHERAL SWELLING 8 0.0001
939 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
940 THERAPEUTIC RESPONSE DECREASED 3 0.0000
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
942 BLINDNESS 2 0.0000
943 SINUSITIS 5 0.0000
944 LUNG NEOPLASM MALIGNANT 2 0.0000
945 DRUG DOSE OMISSION 8 0.0000
946 RHINORRHOEA 3 0.0000
947 DEEP VEIN THROMBOSIS 3 0.0000
948 SWELLING FACE 3 0.0000
949 ANGIOEDEMA 2 0.0000
950 INFLUENZA 5 0.0000
951 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
952 HEPATIC ENZYME INCREASED 3 0.0000
953 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
954 CARDIAC DISORDER 4 0.0000
955 INJURY 3 0.0000
956 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
957 MULTIPLE SCLEROSIS 2 0.0000
958 EPISTAXIS 3 0.0000
959 FLUSHING 4 0.0000
960 PSORIASIS 5 0.0000
961 DERMATITIS ATOPIC 2 0.0000
962 PRODUCT USE ISSUE 7 0.0000
963 URTICARIA 6 0.0000
964 NECK PAIN 2 0.0000
965 ALOPECIA 7 0.0000
966 SURGERY 2 0.0000
967 BLADDER CANCER 2 0.0000
968 DISEASE PROGRESSION 4 0.0000
969 JOINT SWELLING 4 0.0000
970 INJECTION SITE PAIN 10 0.0000
971 ADVERSE EVENT 3 0.0000
972 EXPOSURE DURING PREGNANCY 2 0.0000
973 INCORRECT DOSE ADMINISTERED 7 0.0000
974 PRODUCT DOSE OMISSION 2 0.0000
975 DRY SKIN 4 0.0000
976 NEOPLASM MALIGNANT 2 0.0000
977 CEREBROVASCULAR ACCIDENT 5 0.0000
978 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
979 INJECTION SITE REACTION 2 0.0000
980 DEVICE MALFUNCTION 2 0.0000
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
982 HYPERSENSITIVITY 5 0.0000
983 HOT FLUSH 2 0.0000
984 UNEVALUABLE EVENT 2 0.0000
985 INJECTION SITE BRUISING 2 0.0000
986 INJECTION SITE HAEMORRHAGE 2 0.0000
987 ABORTION SPONTANEOUS 1 0.0000
988 PROSTATE CANCER 2 0.0000
989 THROMBOSIS 2 0.0000
990 EMOTIONAL DISTRESS 3 0.0000
991 GASTROINTESTINAL DISORDER 2 0.0000
992 PRODUCT DOSE OMISSION ISSUE 6 0.0000
993 VISUAL IMPAIRMENT 2 0.0000
994 INJECTION SITE ERYTHEMA 2 0.0000
995 PRODUCT QUALITY ISSUE 2 0.0000
996 ACNE 1 0.0000